Telomir Pharmaceuticals (TELO), a trailblazer in age-reversal research, has announced groundbreaking results demonstrating Telomir-1’s exceptional copper-binding properties. This advancement bolsters the compound’s potential to treat Wilson’s disease, a rare genetic disorder caused by toxic copper accumulation. The findings also expand Telomir’s focus on developing innovative therapies for critical medical challenges. Copper Regulation and Wilson’s Disease […]